We previously reported that NDUFA4L2 is highly expressed at the mRNA and protein levels in ccRCC patients but is not expressed in normal human kidney tissue,8 making it a promising therapeutic target. The gene discussed is COXFA4L2; the disease is nonpapillary renal cell carcinoma.